Are we nearly there yet? Progress in the prevention of sudden cardiac death in the young

Cardiology (Switzerland)

Volumn 127, Issue 4, 2014, Pages 265-274

  Sen Chowdhry, Srijita ^a,b   McKenna, William J ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MARFAN SYNDROME; PRIORITY JOURNAL; RESCREENING; SUDDEN CARDIAC DEATH; T WAVE INVERSION; ADOLESCENT; ADULT; ADVERSE OUTCOME; CHILD; CLINICAL EVALUATION; ELECTROCARDIOGRAM; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HEART PROTECTION; HIGH RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MINORITY GROUP; PATIENT SELECTION; PILOT STUDY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROGNOSIS; RELATIVE; REVIEW; RISK ASSESSMENT; VENTRICULAR NONCOMPACTION; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; DEATH, SUDDEN, CARDIAC; HISTORY; MIDDLE AGED; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOLOGY; CARDIOVASCULAR ABNORMALITIES; CHILD; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84893706125     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000357379     Document Type: Article

References (45)

1. Sen-Chowdhry S, McKenna WJ: Sudden cardiac death in the young: a strategy for prevention by targeted evaluation. Cardiology 2006; 105: 196-206.
2. Padang R, Bagnall RD, Semsarian C: Genetic basis of familial valvular heart disease. Circ Cardiovasc Genet 2012; 5: 569-580.
3. Ehtisham J, Watkins H: Is Wolff-Parkinson-White syndrome a genetic disease? J Cardio-vasc Electrophysiol 2005; 16: 1258-1262.
4. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M: Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997; 77: 130-132.
5. Hamid MS, Norman M, Quraishi A, Firoozi S, Thaman R, Gimeno JR, et al: Prospective evaluation of relatives for familial arrhythmo-genic right ventricular cardiomyopathy/dys-plasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002; 40:1445-1450.
6. Maron BJ, McKenna WJ, Danielson GK, Kap-penberger LJ, Kuhn HJ, Seidman CE, et al: American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardio-myopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003; 24: 1965-1991.
7. Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ: Arrhythmogenic cardiomyop- athy: etiology, diagnosis, and treatment. Annu Rev Med 2010; 61: 233-253.
8. Sen-Chowdhry S, McKenna WJ: Left ventricular noncompaction and cardiomyopathy: cause, contributor, or epiphenomenon? Curr Opin Cardiol 2008; 23: 171-175.
9. Behr E, Wood DA, Wright M, Syrris P, Shep-pard MN, Casey A, et al: Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet 2003; 362: 1457-1459.
10. Corrado D, Basso C, Schiavon M, Thiene G: Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-369.
11. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al: ACC/AHA/ ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48:e247-e346.
12. van der Zwaag PA, van Rijsingen IAW, Asi-maki A, Jongbloed JDH, van Veldhuisen DJ, Wiesfeld ACP, et al: Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopa-thy. Eur J Heart Fail 2012; 14: 1199-1207.
13. Bagnall RD, Ingles J, Semsarian C: Molecular diagnostics of cardiomyopathies: the future is here. Circ Cardiovasc Genet 2011; 4: 103-104.
14. Dipple KM, McCabe ER: Modifier genes convert 'simple' Mendelian disorders to complex traits. Mol Genet Metab 2000; 71: 43-50.
15. Gati S, Chandra N, Bennett RL, Reed M, Ker-vio G, Panoulas VF, et al: Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart 2013; 99: 401-408.
16. Sen-Chowdhry S, Syrris P, Prasad SK, Hughes SE, Merrifield R, Ward D, et al: Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 2008; 52: 2175-2187.
17. Sriram CS, Syed FF, Ferguson ME, Johnson JN, Enriquez-Sarano M, Cetta F, et al: Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol 2013; 62: 222-230.
18. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al: Diagnosis of ar-rhythmogenic right ventricular cardiomyop-athy/dysplasia: proposed modification of the task force criteria. Circulation 2010; 121: 1533-1541.
19. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ: Clinical and genetic characterization of families with ar-rhythmogenic right ventricular dysplasia/car-diomyopathy provides novel insights into patterns of disease expression. Circulation 2007; 115: 1710-1720.
20. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, et al: An entirely subcutaneous implantable cardioverter-defi-brillator. N Engl J Med 2010; 363: 36-44.
21. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al: Safety and efficacy of a totally subcutaneous implantable-cardio-verter defibrillator. Circulation 2013; 128: 944-953.
22. Abozguia K, Elliott P, McKenna W, Phan TT, Nallur-Shivu G, Ahmed I, et al: Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy. Circulation 2010; 122: 1562-1569.
23. Ma D, Wei H, Lu J, Ho S, Zhang G, Sun X, et al: Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2013; 34: 1122-1133.
24. Oh Y, Wei H, Ma D, Sun X, Liew R: Clinical applications of patient-specific induced plu-ripotent stem cells in cardiovascular medicine. Heart 2012; 98: 443-449.
25. Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, et al: Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 2013; 494: 105-110.
26. Panayotova R, Macnab A, Waterworth PD: A pilot project of familial screening in patients with bicuspid aortic valve disease. J Heart Valve Dis 2013; 22: 150-155.
27. Debney MT, Fox KF: Rapid access cardiology - a nine year review. QJM 2012; 105:231-234.
28. Maron B: Cardiovascular disease, sudden cardiac death, and preparticipation screening in young competitive athletes; in Moller JH, Hoffman JIE (eds): Pediatric Cardiovascular Medicine. Hoboken, Wiley-Blackwell, 2012, pp 814-825.
29. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, et al: Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/ cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 2013; 62: 1290-1297.
30. Corrado D, Basso C, Thiene G: Pros and cons of screening for sudden cardiac death in sports. Heart 2013; 99: 1365-1373.
31. Sen-Chowdhry S, McKenna WJ: Sudden death from genetic and acquired cardiomy-opathies. Circulation 2012; 125: 1563-1576.
32. Rasmussen V, Jensen G, Schnohr P, Hansen JF: Premature ventricular beats in healthy adult subjects 20 to 79 years of age. Eur Heart J 1985; 6: 335-341.
33. Kostis JB, McCrone K, Moreyra AE, Gotzo-yannis S, Aglitz NM, Natarajan N, et al: Premature ventricular complexes in the absence of identifiable heart disease. Circulation 1981; 63: 1351-1356.
34. Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ: Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985; 312: 193-197.
35. Bikkina M, Larson MG, Levy D: Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med 1992; 117: 990-996.
36. Abdalla IS, Prineas RJ, Neaton JD, Jacobs DRJ, Crow RS: Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men. Am J Car-diol 1987; 60: 1036-1042.
37. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Frederiksen BS, Davanlou M, et al: Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age > or = 55 years. Am J Cardiol 2006; 97: 1351-1357.
38. Zweytick B, Pignoni-Mory P, Zweytick G, Steinbach K: Prognostic significance of right ventricular extrasystoles. Europace 2004; 6: 123-129.
39. Noda T, Shimizu W, Taguchi A, Aiba T, Sa-tomi K, Suyama K, et al: Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Car-diol 2005; 46: 1288-1294.
40. Wilber DJ: Ventricular ectopic beats: not so benign. Heart 2009; 95: 1209-1210.
41. Tada H, Ito S, Shinbo G, Tadokoro K, Ito I, Hashimoto T, et al: Significance and utility of plasma brain natriuretic peptide concentrations in patients with idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol 2006; 29: 1395-1403.
42. Pelliccia A, Di Paolo FM, Quattrini FM, Basso C, Culasso F, Popoli G, et al: Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 2008; 358: 152-161.
43. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JDJ: Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 2002; 158: 220-235.
44. O'Donoghue C, Esserman L: Recognising the benefits and harms of breast cancer screening: an opportunity to target improvement. Br J Cancer 2013; 108: 2200-2201.
45. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M: The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013; 108: 2205-2240.